Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Get Free Report) shares dropped 0.7% during mid-day trading on Wednesday . The stock traded as low as $67.82 and last traded at $68.02. Approximately 2,083 shares changed hands during trading, a decline of 81% from the average daily volume of 11,162 shares. The stock had previously closed at $68.47.
Invesco Biotechnology & Genome ETF Stock Down 0.7 %
The stock has a market capitalization of $274.80 million, a P/E ratio of 17.12 and a beta of 0.88. The company has a 50 day moving average of $69.83 and a 200-day moving average of $66.35.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of PBE. Ashton Thomas Private Wealth LLC acquired a new stake in Invesco Biotechnology & Genome ETF during the second quarter worth about $26,000. GPS Wealth Strategies Group LLC bought a new stake in shares of Invesco Biotechnology & Genome ETF in the 2nd quarter worth approximately $30,000. UMB Bank n.a. bought a new stake in shares of Invesco Biotechnology & Genome ETF in the 2nd quarter worth approximately $31,000. Covestor Ltd boosted its position in Invesco Biotechnology & Genome ETF by 24.2% during the 1st quarter. Covestor Ltd now owns 955 shares of the company’s stock valued at $62,000 after purchasing an additional 186 shares during the period. Finally, B. Riley Wealth Advisors Inc. bought a new position in Invesco Biotechnology & Genome ETF during the 1st quarter worth $232,000.
About Invesco Biotechnology & Genome ETF
PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.
Further Reading
- Five stocks we like better than Invesco Biotechnology & Genome ETF
- What is Forex and How Does it Work?
- 3 Momentum Trades for October With Ample Upside Ahead
- What Do S&P 500 Stocks Tell Investors About the Market?
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- 3 Stocks to Consider Buying in October
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Invesco Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.